Read on to learn more about the new FDA-approved weight loss pills, how they work, and where they are available
The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me
People with Type 2 diabetes who were treated with GLP-1 medications were found to be less likely to be diagnosed with obesity-associated cancers than people treated with insulin or metformin, according to a new study published July 5 in the medical journal JAMA Network open
Weeks 5 to 8: Fine-tune
Safety of dipeptidyl peptidase 4 inhibitors: a perspective review
This was the first study evaluating the peel of pomegranate as a therapeutic supplement which in regular life is considered as a wastage